Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical stage biotechnology company focused on the discovery, development and commercialization of first in class biological therapies for the treatment of cardiac and other serious medical conditions. I...
Enter your details and select criteria for the jobs you want to receive.
Lead Capricor Therapeutics’ U.S. patient services organization to prepare for and support the launch of deramiocel for Duchenne muscular dystrophy, enabling patient access, affordability, and coordinated treatment initiation.
Capricor Therapeutics seeks a Senior Director, Head of Commercial Operations to build the operational, data, and analytics foundation for the anticipated U.S. launch of deramiocel for Duchenne muscular dystrophy.
